MedEngine

MedEngine Celebrates 10 Years of Innovation and Growth 🥳🎈 A year ago, we proudly announced our partnership with Voisin Consulting Life Sciences (VCLS), a global leader in #Pharma and #HealthTech consulting. This milestone marked a pivotal point in MedEngine’s journey, unlocking exciting new opportunities for the #global expansion of our services. By combining #VCLS ’s extensive expertise—from preclinical and clinical development to regulatory services—with #MedEngine ’s strengths in real-world evidence, market access, and scientific content creation, we have established one of the most comprehensive scientific hubs for the development and launch of innovative therapies. Together, we are well-positioned to serve a diverse range of stakeholders across the life sciences sector, advancing progress and enhancing patient outcomes #worldwide. #10thAnniversary #Celebration #TheValueIsInTheLinks #MarketAccess #ScientificContent #RealWorldEvidence #RWE #InnovativeTherapies #PharmaceuticalIndustry

💡 Seeking to offer valuable scientific experiences? Scientific events serve as invaluable platforms for sharing the latest findings and insights with your target audience in an engaging way. MedEngine stands at the forefront of facilitating this exchange through comprehensive event production services, spanning live #seminars, interactive #webinars, and advisory boards. From initial conceptualization to meticulous execution and post-event material creation, we ensure every detail aligns with your specific vision, ensuring a seamless experience for guests, speakers, and organizers alike. Our pre-event communication aims to pique interest and drive participation, while post-event content creation focuses on conveying key takeaways and fostering long-term engagement with the audience. Customized to your needs, these materials can take various forms, from detailed event reports to captivating infographics or digital content series featuring additional insights from top experts in the field. This approach ensures that the essence of your event and message is captured and conveyed in a manner that resonates with your target audience! Contact us to hear more! Comment below, send a message or email us at [email protected] #MedEngine #TheValueIsInTheLinks #Events #ScientificEvents #Seminar #Webinar #AdvisoryBoard #PharmaceuticalIndustry

📣 Join us at ISPOR Europe 2024, taking place from November 17-20 in vibrant Barcelona! Saku Torvinen, PhD, Kalle Aaltonen, and Tero Ylisaukko-oja from MedEngine will be attending the conference. With a focus on market access, real-world evidence, and innovative healthcare solutions, our team is excited to engage with colleagues! Don't miss the chance to connect and discuss collaboration opportunities in cutting-edge healthcare trends. Check out the website below and book a meeting to explore how we can work together to shape the future of healthcare. https://lnkd.in/dX_EjBNm #MedEngine #TheValueIsInTheLinks #ISPOREurope #HEOR #HealthEconomics #MarketAccess #RWE #Barcelona ISPOR—The Professional Society for Health Economics and Outcomes Research

🤔 Curious about advertorials? Advertorials provide editorial-style content offering valuable insights to the desired target audience. In today’s era of information overload, a well-crafted advertorial with compelling content and an eye-catching layout captures the attention of multiple readers. At MedEngine, we specialize in crafting informative advertorials tailored for healthcare professionals. Our pieces dive into relevant topics by drawing from expert insights and latest publications or updates in treatment practices. MedEngine’s #scientific writers are equipped to ensure that the content meets compliance requirements, conveys your message clearly, and resonates with healthcare professionals. Plus, our secret? We’re all about #storytelling, making our advertorials engaging. Whether in print or online, advertorials can play a vital role in multi-channel strategies. Want to learn more about #advertorials? Reach out to us! #MedEngine #TheValueIsInTheLinks #MedComm #MultiChannel #Strategy

🚨 New Insights on Myasthenia Gravis in Scandinavia A recent study by Piehl et al., published in the European Journal of Neurology, reveals the substantial economic and societal burden of myasthenia gravis (MG) in #Denmark, #Finland, and #Sweden. 💡 Key Highlights: ⚫  Mean annual total costs: €12,200 in Denmark, €9,000 in Finland, and €6,000 per person in Sweden. ⚫  Severe cases incur significantly higher costs, ranging from €19,600 to €33,500 per person annually. ⚫  Factors like disease severity and comorbidities are strongly linked to increased costs. 💎  Conclusion: The study by Piehl et al. highlights the critical link between disease severity and rising healthcare costs in myasthenia gravis patients. It calls for improved management strategies to help reduce the financial burden on both patients and healthcare systems across Denmark, Finland, and Sweden. 🗣️  Let’s discuss how we can better support those impacted by MG! 📄  The original report was published in European Journal of Neurology: https://lnkd.in/dgqBdXbT 📚 Read more of our studies: https://lnkd.in/dPYE6WWi The study was a collaboration among researchers from #MedEngine, Rigshospitalet/University of Copenhagen (Københavns Universitet), University of Helsinki/Helsinki University Central Hospital, Karolinska Institutet, Karolinska University Hospital, and UCB Pharma. #InPress #Study #TheValueIsInTheLinks #MyastheniaGravis #HealthcareResearch #Scandinavia #Neurology #ChronicIllness

🎥 #Videos have become one of the fastest ways to gain attention and learn—also among healthcare professionals and patients. At #MedEngine, we specialize in offering video services that stand out for their #premium quality. Our unique strength lies in our cross-functional team, which combines the expertise of #scientific consultants with the #creative prowess of video production experts. This synergy allows us to cater to a wide array of video needs, ensuring that every aspect, from the initial #scientific scriptwriting to compliance and the final distribution of the product, is handled with precision and professionalism. #MedEngine #TheValueIsInTheLinks #ScientificContent #VideoProduction

Type 1 diabetes affects an estimated 1.2 million children/adolescents under 20 years of age. Glycaemic control is particularly worse during childhood and adolescence, which puts younger individuals at increased risk of developing acute and long-term micro- and macrovascular complications. Aim: We assessed the long-term economic impact of Control-IQ technology automated insulin delivery system treatment utilising pediatric outcomes data from the Region Halland study cohort. 💡 Highlights: ⚫  A four-state Markov model and probabilistic sensitivity analyses were used to assess the cost-effectiveness of the Control-IQ in a pediatric population compared with treatment with multiple daily insulin injections (MDI) or continuous subcutaneous insulin infusion (CSII) in conjunction with continuous glucose monitoring. ⚫  Initiation of therapy with the Control-IQ system in this pediatric population was cost-effective. ⚫  The use of the Control-IQ automated insulin delivery system was less costly compared with MDI and CSII. ⚫  The use of automated insulin delivery systems in children with type 1 diabetes should be recommended as the preferred method of insulin administration compared with insulin pump or multiple daily insulin injections, freestanding or used in combination with real-time continuous glucose monitoring. 💎 Conclusion: Implementing the Control IQ use in children and adolescents with type 1 diabetes already using continuous glucose monitoring is cost-effective and cost saving, improving glycaemic control and increases the quality of life.  Further investigations are needed to more fully elucidate the cost-effectiveness of these technologies in different countries with existing differences in payment models. 📄 The original report was published in DiabeticMedicine (Wiley Online Library): https://lnkd.in/eQwSnnrJ 📚 Read more of our studies: https://lnkd.in/dPYE6WWi 🤝 The study was a collaboration by researchers from #MedEngine, Department of Pediatrics, The Hospital of Halland, Institute of Clinical Sciences, and Sahlgrenska Academy at University of Gothenburg, and Department of Economics, Centre for Health Governance, University of Gothenburg. #InPress #Diabetes #Study #TheValueIsInTheLinks

📢📅 We're excited to announce an upcoming webinar by Voisin Consulting Life Sciences (VCLS) titled "How to Successfully Master Both Market Authorization and Joint Clinical Assessment." Don't miss out—register now and gain valuable insights! #MedEngine #TheValueIsInTheLinks #VCLS #MarketAccess

MedEngine Celebrates 10 Years 🥳🎈 MedEngine began as a local, one-person venture, offering services in scientific content, medical affairs consultancy, and real-world evidence, steadily growing over time. A major turning point came in 2021 with the acquisition of the Institute of Applied Economics and Health Research ApS (ApHER), which expanded our operations into Denmark and Sweden. Simultaneously, we formally launched our Market Access services under the leadership of Saku Torvinen, PhD. These milestones were pivotal in positioning MedEngine as a Nordic leader in medical data science, market access, and digital engagement solutions! #MedEngine #10thAnniversary #TheValueIsInTheLinks #Nordic #PharmaceuticalIndustry

Many thanks to everyone who showed interest in our recent webinar! This exclusive session, featuring Dr. Jussi Leinonen, Strategic Project Lead in the R&D Data Science and Artificial Intelligence division at Bayer, is now available online. Don’t miss future events—subscribe to our newsletter to stay updated on upcoming webinars and gain access to replay videos! ✍️ http://eepurl.com/grYEDf #MedEngine #Webinar #ExternalControlArms #DataScience #TheValueIsInTheLinks